Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Test Type

  2.3.2 Market Size by Pathogen

  2.3.3 Market Size by End Use

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material, Reagent & Diagnostic Component Suppliers

  3.4.2 Diagnostic Test Manufacturers & Technology Developers

  3.4.3 Distribution, Laboratory Services & Healthcare Integration Providers

  3.4.4 End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Infectious Disease Testing & Surveillance Metrics

4.1.1 Share (%) of vector-borne infectious disease diagnostics attributed to arbovirus testing globally.

4.1.2 Growth (%) in arbovirus testing volumes during 2025 and 2026 driven by dengue, Zika, chikungunya, and West Nile virus outbreaks.

4.1.3 Increase (%) in public health surveillance programmes and vector-borne disease monitoring initiatives worldwide.

4.2 Diagnostic Technology & Laboratory Testing Metrics

4.2.1 Share (%) of arbovirus testing demand generated by PCR, ELISA, rapid diagnostic tests, and multiplex molecular assays.

4.2.2 Growth (%) in adoption of point-of-care diagnostics and portable infectious disease testing systems globally.

4.2.3 Increase (%) in utilization of AI-enabled diagnostics and genomic sequencing technologies for outbreak detection and epidemiological analysis.

4.3 Healthcare, Public Health & Research Application Metrics

4.3.1 Share (%) of arbovirus testing demand generated from hospitals, diagnostic laboratories, blood banks, and public health agencies.

4.3.2 Growth (%) in infectious disease screening and blood safety monitoring programmes globally.

4.3.3 Increase (%) in research funding for arbovirus epidemiology, vaccine development, and virology studies worldwide.

4.4 Diagnostic Manufacturing & Supply Chain Metrics

4.4.1 Share (%) of arbovirus diagnostic kit manufacturing concentrated across North America, Europe, and Asia Pacific.

4.4.2 Growth (%) in production capacity for molecular diagnostic reagents and infectious disease testing consumables.

4.4.3 Increase (%) in demand for cold-chain logistics and laboratory automation technologies supporting infectious disease diagnostics.

4.5 Innovation & Regulatory Compliance Metrics

4.5.1 Share (%) of R&D investments focused on multiplex assays, rapid testing platforms, and next-generation sequencing technologies.

4.5.2 Growth (%) in adoption of digital epidemiology and AI-based outbreak prediction systems globally.

4.5.3 Increase (%) in regulatory approvals and emergency authorization initiatives for arbovirus diagnostic technologies.

5. Arbovirus Testing Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

5.1 Introduction

5.2 ELISA-Based Tests

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

5.3 RT-PCR-Based Tests

5.4 Rapid Antigen/Antibody Tests

5.5 Others

6. Arbovirus Testing Market Segmental Analysis & Forecast, By Pathogen, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Dengue

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

   6.3 Zika

   6.4 Chikungunya

   6.5 West Nile Virus

   6.6 Yellow Fever

   6.7 Others

7. Arbovirus Testing Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

7.1 Introduction

7.2 Hospitals

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

7.3 Diagnostic Laboratories

7.4 Research & Academic Institutes

7.5 Others

8. Arbovirus Testing Market Segmental Analysis & Forecast, By Region, 2022 – 2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Arbovirus Testing Market Size & Forecast, By Test Type, 2022–2035

 8.2.3 Arbovirus Testing Market Size & Forecast, By Pathogen, 2022–2035

 8.2.4 Arbovirus Testing Market Size & Forecast, By End Use, 2022–2035

 8.2.5 Arbovirus Testing Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Arbovirus Testing Market Size & Forecast, By Test Type, 2022–2035

 8.3.3 Arbovirus Testing Market Size & Forecast, By Pathogen, 2022–2035

 8.3.4 Arbovirus Testing Market Size & Forecast, By End Use, 2022–2035

 8.3.5 Arbovirus Testing Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Arbovirus Testing Market Size & Forecast, By Test Type, 2022–2035

 8.4.3 Arbovirus Testing Market Size & Forecast, By Pathogen, 2022–2035

 8.4.4 Arbovirus Testing Market Size & Forecast, By End Use, 2022–2035

 8.4.5 Arbovirus Testing Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Arbovirus Testing Market Size & Forecast, By Test Type, 2022–2035

 8.5.3 Arbovirus Testing Market Size & Forecast, By Pathogen, 2022–2035

 8.5.4 Arbovirus Testing Market Size & Forecast, By End Use, 2022–2035

 8.5.5 Arbovirus Testing Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Arbovirus Testing Market Size & Forecast, By Test Type 2022–2035

 8.6.3 Arbovirus Testing Market Size & Forecast, By Pathogen, 2022–2035

 8.6.4 Arbovirus Testing Market Size & Forecast, By End Use, 2022–2035

 8.6.5 Arbovirus Testing Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 South Africa

  8.6.5.5 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022 – 2035

  9.2.3 Number of Strategies Adopted by Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features by Key Players

  9.4.2 Product/Service Heatmap by Key Players

  9.4.3 Application Heatmap by Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 Roche Diagnostics

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

9.6.2 Abbott Laboratories

9.6.3 bioMerieux S.A.

9.6.4 Hologic Inc.

9.6.5 Thermo Fisher Scientific

9.6.6 Bio-Rad Laboratories

9.6.7 Qiagen N.V.

9.6.8 SD Biosensor Inc.

9.6.9 InBios International Inc.

9.6.10 Eurofins Scientific

9.6.11 Altona Diagnostics GmbH

9.6.12 RealStar (altona)

9.6.13 Biopanda Reagents

9.6.14 CTK Biotech Inc.

9.6.15 OraSure Technologies

9.6.16 Vela Diagnostics

9.6.17 Luminex Corporation (DiaSorin)

9.6.18 Siemens Healthineers

9.6.19 Novabay Pharmaceuticals

9.6.20 Chembio Diagnostics

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List of Tables

 13.2 List of Figures